<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709718</url>
  </required_header>
  <id_info>
    <org_study_id>U23464</org_study_id>
    <nct_id>NCT04709718</nct_id>
  </id_info>
  <brief_title>Surgical Management of Giant Hepatic Hemangioma</brief_title>
  <official_title>Surgical Management of Giant Hepatic Hemangioma: a 10-year Single Center Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sousse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahloul Hospital of Sousse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Sousse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatic hemangiomas are the commonest benign mesenchymal lesions of the liver. Most of these&#xD;
      lesions are asymptomatic. Giant hepatic hemangiomas (GHH) (&gt; 10 cm) are often symptomatic and&#xD;
      require surgical intervention. This study aimed to describe the clinical findings, risk&#xD;
      factors, diagnostic approach and management of GHH.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hepatic hemangiomas are the most common benign tumors of the liver with the incidence of 0.4&#xD;
      to 20% . They are most often discovered incidentally on imaging studies. Typical hemangiomas&#xD;
      usually do not increase in size over time and therefore are unlikely to cause symptoms. Giant&#xD;
      hepatic hemangiomas (GHH) are defined as hemangiomas larger than 5 cm . They are usually&#xD;
      responsible for overt clinical symptoms and complications consisting, most often, of upper&#xD;
      abdominal pain, hemorrhage, biliary compression, or a consumptive coagulopathy that may&#xD;
      require prompt surgical intervention or other treatments . Management of liver hemangiomas&#xD;
      ranges from close observation to surgery depending upon the site, size and symptoms .&#xD;
&#xD;
      It is widely accepted that intervention is indicated only for symptomatic hemangiomas.&#xD;
      Surgical resection is indicated in patients with abdominal complaints or complications, or&#xD;
      when diagnosis remains inconclusive. The ideal surgical treatment for GHH is still&#xD;
      controversial. Enucleation is the preferred surgical method based on the existing literature.&#xD;
      In this study, we report our 17-year experience of clinical management of GHH.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2008</start_date>
  <completion_date type="Actual">January 2, 2020</completion_date>
  <primary_completion_date type="Actual">June 29, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of patient getting good result after surgery</measure>
    <time_frame>1 year</time_frame>
    <description>patient asymptomatic after surgery or not</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Liver Angioma</condition>
  <arm_group>
    <arm_group_label>churgery of geant liver hemangioma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hepatectomy</intervention_name>
    <description>liver resection taking over the liver hemangioma</description>
    <arm_group_label>churgery of geant liver hemangioma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient with symptomatic geant liver hemangioma&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Radiological diagnosis of geant liver hamangioma.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Radiological diagnosis of liver hemangioma less than 10cm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>waad farhat, doctor</last_name>
    <role>Study Director</role>
    <affiliation>university of sousse</affiliation>
  </overall_official>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 1, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sousse</investigator_affiliation>
    <investigator_full_name>ammar houssem</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemangioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

